| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 193.02M | 186.82M | 160.12M | 141.57M | 119.06M | 102.03M |
| Gross Profit | 50.20M | 48.57M | 42.44M | 26.79M | 28.71M | 26.93M |
| EBITDA | 19.68M | 17.46M | 20.20M | 5.08M | 8.61M | 8.19M |
| Net Income | 10.61M | 9.03M | 11.37M | 924.00K | 3.31M | 3.23M |
Balance Sheet | ||||||
| Total Assets | 98.27M | 90.55M | 81.65M | 69.00M | 70.87M | 60.07M |
| Cash, Cash Equivalents and Short-Term Investments | 21.22M | 16.73M | 13.20M | 4.44M | 9.23M | 7.93M |
| Total Debt | 220.00K | 117.00K | 2.92M | 6.68M | 7.46M | 3.11M |
| Total Liabilities | 19.57M | 18.64M | 21.22M | 21.43M | 21.74M | 13.21M |
| Stockholders Equity | 78.70M | 71.91M | 60.44M | 47.57M | 49.13M | 46.85M |
Cash Flow | ||||||
| Free Cash Flow | 1.32M | 6.26M | 12.59M | 538.00K | 3.64M | 4.49M |
| Operating Cash Flow | 8.63M | 12.96M | 16.94M | 3.99M | 5.56M | 6.38M |
| Investing Cash Flow | -1.98M | -6.68M | -4.41M | -4.03M | -7.14M | -1.89M |
| Financing Cash Flow | -65.00K | -2.75M | -3.78M | -4.75M | 2.88M | -405.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | $428.88M | 92.57 | 17.44% | ― | 19.34% | -12.64% | |
| ― | $237.73M | 18.07 | 9.15% | ― | 4.33% | -6.33% | |
| ― | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
| ― | $386.45M | 23.76 | 3.20% | ― | 5.88% | -68.62% | |
| ― | $365.34M | 34.71 | 14.46% | ― | 9.19% | -23.91% | |
| ― | $347.52M | -9.76 | -89.88% | ― | -4.59% | -19.09% | |
| ― | $417.66M | ― | -27.07% | ― | 13.05% | -72.80% |
On October 29, 2025, Lifeway Foods, Inc. announced an extension of its Shareholder Rights Agreement by one year, now expiring on October 29, 2026. The decision was made to protect against potential acquisition of control by shareholders without paying a premium, given the company’s concentrated share ownership and the potential for a substantial number of shares to become available for sale. This move aims to ensure that all shareholders can realize the full value of their investment and safeguard against control tactics without fair compensation.
The most recent analyst rating on (LWAY) stock is a Hold with a $25.00 price target. To see the full list of analyst forecasts on Lifeway Foods stock, see the LWAY Stock Forecast page.
Lifeway Foods, Inc. announced that its 2025 annual meeting of shareholders is scheduled for December 16, 2025. Shareholder proposals or nominations must be submitted by October 20, 2025, adhering to the company’s by-laws and Rule 14a-8 requirements.
The most recent analyst rating on (LWAY) stock is a Buy with a $33.00 price target. To see the full list of analyst forecasts on Lifeway Foods stock, see the LWAY Stock Forecast page.
On October 1, 2025, Jody Levy resigned from her position as a director at Lifeway Foods, Inc., a company known for its production of probiotic and functional foods. Her resignation was not due to any disagreements with the company’s operations, policies, or practices.
The most recent analyst rating on (LWAY) stock is a Buy with a $33.00 price target. To see the full list of analyst forecasts on Lifeway Foods stock, see the LWAY Stock Forecast page.
On September 30, 2025, Lifeway Foods, Inc. announced a Cooperation Agreement with Danone North America PBC, which includes a stay of litigation related to a Stockholders’ Agreement and plans for a board refreshment. The agreement outlines governance changes, including the appointment of independent directors and the separation of the Chair and CEO roles. Danone has agreed to support the board’s director candidates at upcoming annual meetings and to waive certain rights under the Stockholders’ Agreement. This strategic move aims to enhance corporate governance and maximize shareholder value while maintaining stability and focus on Lifeway’s core mission.
The most recent analyst rating on (LWAY) stock is a Hold with a $29.00 price target. To see the full list of analyst forecasts on Lifeway Foods stock, see the LWAY Stock Forecast page.
On September 18, 2025, Lifeway Foods announced that Danone has withdrawn its proposal to acquire the company. Lifeway remains focused on executing its strategic plan to enhance shareholder value, having formed a Strategic Review Committee to oversee opportunities. The company reported record-breaking sales in Q1 and Q2 2025, with continued growth into Q3, highlighting its strong market position and consistent performance.
The most recent analyst rating on (LWAY) stock is a Buy with a $33.00 price target. To see the full list of analyst forecasts on Lifeway Foods stock, see the LWAY Stock Forecast page.
On September 2, 2025, Lifeway Foods announced estimated unaudited net sales of $39.1 million for the first two months of the third quarter, marking a 20% increase from the previous year. This growth highlights the company’s strong market position and increasing consumer demand for its kefir and high-protein cheese products, reinforcing its leadership in the probiotic nutrition sector.
The most recent analyst rating on (LWAY) stock is a Buy with a $33.00 price target. To see the full list of analyst forecasts on Lifeway Foods stock, see the LWAY Stock Forecast page.
Lifeway Foods, Inc. is a leading U.S. supplier of kefir and fermented probiotic foods, recognized for its innovative products in the dairy industry.
Lifeway Foods reported record financial results for the second quarter of 2025, with net sales reaching $53.9 million, marking an 18% increase on a comparable basis. The company also announced a strong start to the third quarter with estimated net sales of $26.4 million through August 11, 2025, reflecting a 20% year-over-year growth. This performance underscores Lifeway’s leadership in the kefir category and its ability to capitalize on consumer trends towards wellness and probiotic foods. The company was recognized as Processor of the Year by Dairy Foods magazine, highlighting its innovation and impact in the dairy industry.
The most recent analyst rating on (LWAY) stock is a Buy with a $28.00 price target. To see the full list of analyst forecasts on Lifeway Foods stock, see the LWAY Stock Forecast page.